glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven White House, Novo Nordisk, Lilly
Pay in 4 interest-free payments of $6.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
![glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven White House, Novo Nordisk, Lilly](https://cdn.sanity.io/images/0vv8moc6/medec/11faedd4cc7afc7edb49d055d5df11bd9ac112b7-1200x822.jpg)
![glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven White House, Novo Nordisk, Lilly](https://cloudfront-us-east-2.images.arcpublishing.com/reuters/UCYK4LW2OVMXRJPCUA4OALQFS4.jpg)
![glp-1 white house The aggressively denied a report that implied President Trump may have received the investigational obesity medication retatrutide. "Because this has to be spelled out for [Lizzy Lawrence], who has proven White House, Novo Nordisk, Lilly](https://images.everydayhealth.com/images/2025/trump-weight-loss-drug-deal-medicare-coverage-lower-prices-1440x810.jpg?w=576)






















